Exploring Biomarkers in MS – A New Frontier
March 2024 Exploring MS biomarkers holds great potential for transforming the landscape of MS management, enabling better diagnostics, earlier interventions,…
Dark rim on MS lesions seen with standard MRI may mark activity
Possible way of spotting in clinic rim lesions known to drive progression By Marisa Wexler, MS on 02/26/2024 An imaging…
Stuart Schlossman
MS and Mental Decline: 7 Strategies To Improve Memory and More
Medically reviewed by Amit M. Shelat, D.O. * Written by Brooke Dulka, Ph.D. and Kelly Crumrin Multiple sclerosis (MS) often causes cognitive symptoms such as problems…
Stuart Schlossman
Confronting the Complicated Challenge of Multiple Sclerosis Pain
For many people with multiple sclerosis (MS), chronic pain is an ever-present companion that hampers their quality of life. Treating…
Stuart Schlossman
CHAIR PILATES for the MS community
For anybody wanting to catch up on some of #MSViewsandNews‘ previous #pilates classes, take a look at what you have…
Stuart Schlossman
PRESS RELEASE: Positive Phase III Results for Genentech’s Ocrevus (ocrelizumab) Twice a Year, 10-Minute Subcutaneous Injection in Patients With Multiple Sclerosis
Wednesday, Jul 12, 2023 Phase III OCARINA II trial met primary and secondary endpoints Ocrevus 10-minute injection has the…
Stuart Schlossman
Lower-dose gadolinium now being used for MRIs with contrast
by Ed Tobias | February 24, 2023 If you have multiple sclerosis (MS), I’m sure you’ve had several MRIs by now. You’ve probably also…
Stuart Schlossman
Walking Difficulties Improve for MS Patients With Natural Supplement
Using MS14, a natural product from Persian medicine, led to physical activity gains by Lindsey Shapiro, PhD | December 28, 2022 Daily use…
Stuart Schlossman
Obstacles to access: Despite barriers, people of color with MS are speaking up for themselves and their communities.
by Elaine Shelly People of color living with multiple sclerosis (MS) face challenges beyond differences in symptoms, diagnosis and treatment.…
Stuart Schlossman
Molecular biomarkers in multiple sclerosis
Abstract Multiple sclerosis (MS) is an inflammatory-neurodegenerative disease of the central nervous system presenting with significant inter- and intraindividual…
Stuart Schlossman
